Regional fat loss from the thigh in obese women after adrenergic modulation

Clin Ther. 1987;9(6):663-9.

Abstract

Beta-adrenergic stimulation and alpha 2-adrenergic inhibition increase lipolysis from fat cells. Twenty-eight obese women were placed on a calorie-restricted diet and one of five treatments was applied to one thigh three to five times per week for four weeks: (1) isoproterenol injections; (2) cream containing colforsin (forskolin), aminophylline, and yohimbine; (3) yohimbine cream; (4) colforsin cream; or (5) aminophylline cream. The opposite thigh was treated with a placebo (injection or cream). The treated thighs lost significantly more girth after treatment, both by injection and by cream. No adverse reactions were attributable to either the cream or the injections. It is concluded that local fat reduction from the thigh can be safely accomplished.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adipose Tissue / metabolism
  • Administration, Cutaneous
  • Adrenergic alpha-Antagonists / administration & dosage
  • Adrenergic alpha-Antagonists / therapeutic use*
  • Adrenergic beta-Agonists / administration & dosage
  • Adrenergic beta-Agonists / therapeutic use*
  • Clinical Trials as Topic
  • Double-Blind Method
  • Female
  • Humans
  • Injections
  • Lipolysis / drug effects
  • Obesity / drug therapy*
  • Obesity / metabolism
  • Phosphodiesterase Inhibitors / administration & dosage
  • Phosphodiesterase Inhibitors / therapeutic use
  • Thigh

Substances

  • Adrenergic alpha-Antagonists
  • Adrenergic beta-Agonists
  • Phosphodiesterase Inhibitors